Antibiotic administration
Phase 2Small molecule
Antibiotic administration is one of 10 small molecule programs targeting Endometritis. It is currently in Phase 2.
1
Indications
2
Total Trials
0
Active Trials
9
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
16 competitors in Endometritis
#DrugCompanyPhaseTrials
1Acanya
PfizerApproved
Ancef
BBaxter Healthcare Corporation
Approved
Rocephin
CConrado Roberto Hoffmann Filho
Approved
Invanz
CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Approved
Betadine
BBecton, Dickinson and Company
Preclinical
Oral Administration
BBiomind Labs Inc.
Phase 2
Zithromax
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Preclinical
Peridex
MMedline Industries
Preclinical
Antibiotic administration
UUniversity of California, San Diego
Phase 2
Antibiotics
MMelinta Therapeutics, Inc.
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Antibiotic administration. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details